Buprenorphine vs alpha2‐adrenergic agonists
Number experiencing adverse effects · Adults or adolescents with opioid dependence
It is very uncertain whether buprenorphine changes number experiencing adverse effects compared with alpha2‐adrenergic agonists (very low certainty).
1 finding from 1 review
- RR 0.93 [0.7, 1.26]3 studies · 493 participantsVery low